Systemic immunosuppressive agents were used by 85.7% and 78.5% of patients, respectively. Over time, patients with ANCA-positive vasculitis experienced 2.75-fold higher mortality than other patients with inflammatory eye disease. Ocular disease in patients with ANCA-positive vasculitis

Angela S. Watkins, John H. Kempen, Dongseok Choi, Teresa L. Liesegang, S. S. Pujari, Craig Newcomb, Robert B. Nussenblatt, James T. Rosenbaum, Jennifer E. Thorne, C. Stephen Foster, Douglas A. Jabs, Grace A. Levy-Clarke, Eric B. Suhler, Justine R. Smith

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'Systemic immunosuppressive agents were used by 85.7% and 78.5% of patients, respectively. Over time, patients with ANCA-positive vasculitis experienced 2.75-fold higher mortality than other patients with inflammatory eye disease. Ocular disease in patients with ANCA-positive vasculitis'. Together they form a unique fingerprint.

Medicine & Life Sciences